DE602007011766D1 - Zusammensetzung mit nicht-psychotropen Cannabinoiden zur Behandlung von Entzündungserkrankungen - Google Patents

Zusammensetzung mit nicht-psychotropen Cannabinoiden zur Behandlung von Entzündungserkrankungen

Info

Publication number
DE602007011766D1
DE602007011766D1 DE602007011766T DE602007011766T DE602007011766D1 DE 602007011766 D1 DE602007011766 D1 DE 602007011766D1 DE 602007011766 T DE602007011766 T DE 602007011766T DE 602007011766 T DE602007011766 T DE 602007011766T DE 602007011766 D1 DE602007011766 D1 DE 602007011766D1
Authority
DE
Germany
Prior art keywords
treatment
inflammatory diseases
composition
psychotropic cannabinoids
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007011766T
Other languages
English (en)
Inventor
Blanco Eduardo Munoz
Giovanni Appendino
Bernd L Fiebich
Giampaolo Grassi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vivacell Biotechnology Espana SL
Original Assignee
Vivacell Biotechnology Espana SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivacell Biotechnology Espana SL filed Critical Vivacell Biotechnology Espana SL
Publication of DE602007011766D1 publication Critical patent/DE602007011766D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602007011766T 2007-10-02 2007-10-02 Zusammensetzung mit nicht-psychotropen Cannabinoiden zur Behandlung von Entzündungserkrankungen Active DE602007011766D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07117778A EP2044935B1 (de) 2007-10-02 2007-10-02 Zusammensetzung mit nicht-psychotropen Cannabinoiden zur Behandlung von Entzündungserkrankungen

Publications (1)

Publication Number Publication Date
DE602007011766D1 true DE602007011766D1 (de) 2011-02-17

Family

ID=38969403

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007011766T Active DE602007011766D1 (de) 2007-10-02 2007-10-02 Zusammensetzung mit nicht-psychotropen Cannabinoiden zur Behandlung von Entzündungserkrankungen

Country Status (8)

Country Link
US (1) US20100222437A1 (de)
EP (1) EP2044935B1 (de)
JP (1) JP2010540587A (de)
AT (1) ATE493977T1 (de)
CA (1) CA2701368A1 (de)
DE (1) DE602007011766D1 (de)
ES (1) ES2359168T3 (de)
WO (1) WO2009043836A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
CN102905565B (zh) * 2010-05-21 2016-08-24 环球蒸汽商标公司 制备用于电吸烟设备的烟草提取物的方法
GB2496688B (en) 2011-11-21 2016-06-29 Gw Pharma Ltd Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases
GB2515312A (en) * 2013-06-19 2014-12-24 Gw Pharma Ltd The use of phytocannabinoids in the treatment of ovarian carcinoma
US8906429B1 (en) * 2013-12-11 2014-12-09 Jeffrey A. Kolsky Medical cannabis lozenges and compositions thereof
US20160000843A1 (en) * 2014-07-01 2016-01-07 MJAR Holdings, LLC High cannabidiol cannabis strains
US9687469B2 (en) 2014-11-26 2017-06-27 University Of Maryland, Baltimore Agent containing flavonoid derivatives for treating cancer and inflammation
WO2016178713A1 (en) * 2015-05-02 2016-11-10 Flavocure Biotech Llc Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancers
CA2977421C (en) * 2015-01-22 2022-10-18 Phytoplant Research S.L. Methods of purifying cannabinoids, compositions and kits thereof
US10207198B2 (en) 2015-01-22 2019-02-19 Phytoplant Research S.L. Methods of purifying cannabinoids using liquid:liquid chromatography
US11034639B2 (en) 2015-01-22 2021-06-15 Phytoplant Research S.L. Methods of purifying cannabinoids using liquid:liquid chromatography
US10155708B2 (en) 2015-01-22 2018-12-18 Phytoplant Research S.L. Methods of purifying cannabinoids, compositions and kits thereof
US20180074045A1 (en) * 2015-05-27 2018-03-15 Cannabics Pharmaceuticals Inc System and method for high throughput screening of cancer cells
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
EP3664795A4 (de) 2017-08-09 2021-04-28 Cannibite BVBA Cannabis und derivate davon zur behandlung von schmerzen und entzündungen im zusammenhang mit zahnmark und knochenregeneration im zusammenhang mit kieferknochendefekten
US20200405685A1 (en) * 2017-12-08 2020-12-31 Biotech Institute, Llc High cannabigerol cannabis plants, methods of producing and methods of using them
EP3502692A1 (de) 2017-12-20 2019-06-26 Aposcience AG Wirksamkeitstest für sekretom
EP3745884A1 (de) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hanfpulver
EP3749297A4 (de) 2018-02-07 2021-04-14 SCF Pharma Inc. Mehrfach ungesättigte fettsäuremonoglyceride, zusammensetzungen, verfahren und verwendungen davon
AU2019251357B2 (en) 2018-04-09 2023-10-05 Portland Technology Holdings Llc Hemp extract for treatment of pain in animals
WO2019211771A1 (en) * 2018-05-03 2019-11-07 Radient Technologies Inc. Water soluble and water dispersible formulations of cannabinoids
EP3864000A4 (de) 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. Synthese von cannabigerol
WO2020252369A1 (en) * 2019-06-14 2020-12-17 Purisys Llc Crystalline cannabigerol
CN115087454A (zh) * 2019-12-19 2022-09-20 史蒂文·罗斯斯坦 富含多酚化合物的提取物以及相关方法
WO2022232825A1 (en) * 2021-04-28 2022-11-03 Demetrix, Inc. Use of cannabinoids in the treatment of oral inflammation and periodontal disease
CN113368086B (zh) * 2021-08-11 2021-12-03 龙麻(上海)医药研发有限责任公司 一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用
WO2023239415A1 (en) * 2022-06-08 2023-12-14 Angrow Company Limited Compositions including cannabinoid and use thereof in the manufacture of a medicament for the treatment of inflammation in a subject

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807639D0 (en) * 1998-04-14 1998-06-10 Kennedy Rheumatology Inst Anti-inflammatory agents
US6403126B1 (en) * 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
GB2418612A (en) * 2004-10-01 2006-04-05 Gw Pharma Ltd Inhibition of tumour cell migration with cannabinoids

Also Published As

Publication number Publication date
ES2359168T3 (es) 2011-05-19
CA2701368A1 (en) 2009-04-09
JP2010540587A (ja) 2010-12-24
EP2044935B1 (de) 2011-01-05
US20100222437A1 (en) 2010-09-02
ATE493977T1 (de) 2011-01-15
EP2044935A1 (de) 2009-04-08
WO2009043836A1 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
ATE493977T1 (de) Zusammensetzung mit nicht-psychotropen cannabinoiden zur behandlung von entzündungserkrankungen
BRPI0818672A2 (pt) 2'-fluor-2'-desoxitetra-hidrouridinas como inibidores da citidina desaminase
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
NZ734714A (en) Methods of purifying cannabinoids, compositions and kits thereof
MX2010005114A (es) Uso de las soluciones de aceite de menta o de l-carvona para el tratamiento fungicida y/o antigerminacion de bulbos y/o tuberculos.
EP2192911B8 (de) Pflanzenextrakt aus thc-armen cannabis zur behandlung von erkrankungen
WO2008011363A3 (en) Quercetin-containing compositions
CR20110103A (es) Heteroarilos sustituidos
MY157119A (en) Process for the production of alpha-tocotrienol and derivatives
ATE449097T1 (de) Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
GT200600327A (es) Ciclohexilaminoisoquinolona
BRPI0715763A2 (pt) tratamento ou prevenÇço de cÂnceres superexpressando reg4 ou kiaa0101
TW200732296A (en) Novel compounds
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
ATE544804T1 (de) Teilaromatisches copolyamid und herstellungsverfahren dafür
TW200602341A (en) Processes and intermediates
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
BRPI0514149A (pt) método de produção de planta de soja que apresenta toleráncia ou toleráncia aumentada à infecção por fusarium solani, método e sistema de identificação de planta ou germoplasma de soja sob suspeita de ou apresentando toleráncia, toleráncia aumentada ou susceptibilidade à infecção por fusarium solani, e composição compreendendo par de iniciadores de amplificação
MX2009007911A (es) Inhibidores de proteina tirosina fosfatasa 1b aromaticos fusionados.
CR20120281A (es) Composiciones repelentes y métodos genéticos para controlar huanglogbing en cítricos
EA201170640A1 (ru) Дизамещенные фталазины-антагонисты сигнального пути hedgehog
CL2007002388A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de hemangiomas o hemangioblastomas.
EA201170567A1 (ru) Смесь силанов
WO2009126672A3 (en) 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides
DK1562447T3 (da) Antioxidative sammensætninger